Cubist Pharmaceuticals, Inc. (NASDAQ: CBST) reported Q4 EPS of $0.29, versus $0.42 last year. The results may not compare ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE